Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Clinical and laboratory characteristics according to bone histological phenotype. | Normalbone histology(n = 23, 41.1%) | Low-turnoverbone disease(n = 20, 35.7%) | High-turnoverbone disease (n = 12, 21.4%) | P value: 25(OH)D (ng/ml) | 15 (11, 22) | 16 (13, 23) | 15 (9, 22) | 0.887

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a cross-sectional study of 56 adults with CKD stages 3 to 4 who underwent transiliac bone biopsy with quantitative histomorphometry following double tetracycline labeling.

Source: Abstract.

Eligible participants were aged ≥18 years and had an estimated glomerular filtration rate (eGFR) between 15 and 60 ml/min/1.73 m².

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Albuminuria is associated with higher turnover-related bone histomorphometric indices in chronic kidney disease stages 3 to 4

Cross-sectional study · Clinical Kidney Journal · 2026

Original publication title

Albuminuria is associated with higher turnover-related bone histomorphometric indices in chronic kidney disease stages 3 to 4

Ricardo Neto; Bernardo Fernandes; Juliana Magalhães; Inês Alencastre; João Frazão

© The Author(s) 2026. Published by Oxford University Press on behalf of the ERA.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In patients with CKD stages 3 to 4, higher urinary albumin excretion was independently associated with quantitative histomorphometric indices of higher bone turnover. These findings suggest that albuminuria may mark a bone remodeling phenotype not fully captured by eGFR, iPTH, and FGF23. Larger prospective studies are needed to define the biological basis and clinical implications of this association.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Biological determinants of bone turnover in chronic kidney disease (CKD) remain incompletely understood. Although albuminuria is an established marker of kidney damage and predictor of renal and cardiovascular outcomes, its relationship with bone remodeling, as assessed by quantitative bone histomorphometry, has not previously been investigated.

Source: Background

Abstract: What methods does the paper describe?

We performed a cross-sectional study of 56 adults with CKD stages 3 to 4 who underwent transiliac bone biopsy with quantitative histomorphometry following double tetracycline labeling. Associations between 24-h urinary albumin excretion and individual bone histomorphometric parameters were evaluated using multivariable linear regression. Models were adjusted for age, sex, estimated glomerular filtration rate (eGFR), intact parathyroid hormone (iPTH), and fibroblast growth factor 23 (FGF23).

Source: Methods

Abstract: Results

In multivariable analyses, higher 24-h urinary albumin excretion was associated with a histomorphometric pattern consistent with increased bone turnover, reflected by greater bone formation and cell surface indices. Specifically, log₁₀-transformed urinary albumin excretion was associated with higher bone formation rate (B = 0.295, 95% CI 0.088 to 0.501; P = 0.008), osteoblast surface (B = 0.588, 95% CI 0.187 to 0.988; P = 0.005) and osteoclast surface (B = 0.464, 95% CI 0.041 to 0.887; P = 0.033).

Associations with mineralization-related parameters and bone volume were not statistically significant.

Source: Results

Abstract: Conclusions

In patients with CKD stages 3 to 4, higher urinary albumin excretion was independently associated with quantitative histomorphometric indices of higher bone turnover. These findings suggest that albuminuria may mark a bone remodeling phenotype not fully captured by eGFR, iPTH, and FGF23. Larger prospective studies are needed to define the biological basis and clinical implications of this association.

Source: Conclusions
Authors’ abstract

ABSTRACT

Background

Biological determinants of bone turnover in chronic kidney disease (CKD) remain incompletely understood. Although albuminuria is an established marker of kidney damage and predictor of renal and cardiovascular outcomes, its relationship with bone remodeling, as assessed by quantitative bone histomorphometry, has not previously been investigated.

Methods

We performed a cross-sectional study of 56 adults with CKD stages 3 to 4 who underwent transiliac bone biopsy with quantitative histomorphometry following double tetracycline labeling. Associations between 24-h urinary albumin excretion and individual bone histomorphometric parameters were evaluated using multivariable linear regression. Models were adjusted for age, sex, estimated glomerular filtration rate (eGFR), intact parathyroid hormone (iPTH), and fibroblast growth factor 23 (FGF23).

Results

In multivariable analyses, higher 24-h urinary albumin excretion was associated with a histomorphometric pattern consistent with increased bone turnover, reflected by greater bone formation and cell surface indices. Specifically, log₁₀-transformed urinary albumin excretion was associated with higher bone formation rate (B = 0.295, 95% CI 0.088 to 0.501; P = 0.008), osteoblast surface (B = 0.588, 95% CI 0.187 to 0.988; P = 0.005) and osteoclast surface (B = 0.464, 95% CI 0.041 to 0.887; P = 0.033).

Associations with mineralization-related parameters and bone volume were not statistically significant.

Conclusions

In patients with CKD stages 3 to 4, higher urinary albumin excretion was independently associated with quantitative histomorphometric indices of higher bone turnover. These findings suggest that albuminuria may mark a bone remodeling phenotype not fully captured by eGFR, iPTH, and FGF23. Larger prospective studies are needed to define the biological basis and clinical implications of this association.

Publication and source details

Original title: Albuminuria is associated with higher turnover-related bone histomorphometric indices in chronic kidney disease stages 3 to 4

Ricardo Neto; Bernardo Fernandes; Juliana Magalhães; Inês Alencastre; João Frazão

Clinical Kidney Journal · 2026

Correspondence to: Ricardo Neto; E-mail: ricardoneto76@gmail.com© The Author(s) 2026. Published by Oxford University Press on behalf of the ERA.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Fundação para a Ciência e a Tecnologia10.13039/501100001871 UID/06397/2025

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:36:14.662692+00:00

DOI: 10.1093/ckj/sfag346 · PMC13655740